ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Horizon bulks up sales force ahead of $750M inflammatory eye drug launch fiercepharma
June 28, 2019Horizon Therapeutics—until recently known as Horizon Pharma—is headed for an FDA filing for its inflammatory eye drug teprotumumab. To prepare for the potential launch, the company has set out to expand its sales team. -
Oral Steroids Increase Infection Risk in Inflammatory Disease drugs
June 25, 2019Oral Steroids Increase Infection Risk in Inflammatory Disease. -
IL-18 inhibitor drug holds great potential for inflammatory diseases europeanpharmaceuticalreview
April 26, 2019An international team of researchers has identified the key role that IL-18 protein plays in Still’s disease, making it a prime candidate for IL-18 inhibitor drug that is proving promising in current trials. -
Sanofi signs $1bn drug development deal with Denali Therapeutics
pharmaceutical-technology
November 06, 2018Sanofi has entered a deal valued at more than $1bn with US-based Denali Therapeutics to advance potential drug candidates for the treatment of neurological and systemic inflammatory diseases.
Pharma Sources Insight July 2025
